const kidneyTumorAblation = {
    "page": {
        "type": "procedure",
        "specialty": "urology",
        "slug": "/specialties/urology/procedures/kidney-tumor-ablation"
    },
    "metadata": {
        "title": "Kidney Tumor Ablation (Cryo/Microwave/RFA): Candidacy, Benefits, Risks | MyDocsy (Mumbai, Delhi NCR, Bangalore, Ahmedabad, Hyderabad, Chennai, Kochi, Kolkata, Pune)",
        "description": "Kidney tumor ablation can treat selected small, localized renal tumors using energy (cryo, microwave, or RFA) without removing the kidney. A doctor-written guide to candidacy, imaging and biopsy decisions, how ablation is performed, recovery, risks, and follow-up."
    },
    "blocks": [
        {
            "type": "text",
            "title": "Kidney tumor ablation: a kidney-sparing option\u2014only when the tumor pattern is truly suitable",
            "content": "Ablation can sound immediately attractive because it is less invasive than surgery. For selected kidney tumors, it can be an excellent option\u2014especially when: the tumor is small and localized, the location is favourable for safe targeting, preserving kidney function is important, surgical risk is higher.\n\nBut ablation is not a shortcut around good cancer care. It is a treatment option within a structured kidney tumor pathway, and the decision must be anatomy- and risk-based."
        },
        {
            "type": "links",
            "title": "Quick navigation",
            "items": [
                {
                    "href": "#what-ablation-means",
                    "label": "What ablation means"
                },
                {
                    "href": "#when-recommended",
                    "label": "When ablation is recommended"
                },
                {
                    "href": "#when-not-appropriate",
                    "label": "When ablation may not be appropriate"
                },
                {
                    "href": "#evaluation",
                    "label": "What evaluation is needed"
                },
                {
                    "href": "#tool-choice",
                    "label": "Cryo vs microwave vs RFA"
                },
                {
                    "href": "#procedure",
                    "label": "How ablation is performed"
                },
                {
                    "href": "#recovery",
                    "label": "Recovery and timelines"
                },
                {
                    "href": "#risks",
                    "label": "Risks and side effects"
                },
                {
                    "href": "#follow-up",
                    "label": "Follow-up after ablation"
                },
                {
                    "href": "#comparison",
                    "label": "Ablation vs partial nephrectomy"
                },
                {
                    "href": "#faqs",
                    "label": "FAQs"
                },
                {
                    "href": "#consult",
                    "label": "Talk to a doctor"
                }
            ]
        },
        {
            "type": "text",
            "title": "What 'ablation' means",
            "content": "Ablation means destroying tumor tissue in place using energy, without surgically removing the tumor as a specimen.\n\nCommon energy tools include: Cryoablation (freezing), Microwave ablation (heating), Radiofrequency ablation (RFA) (heating).\n\nThe goal is: to treat a localized tumor reliably, while preserving as much healthy kidney tissue as possible.\n\nAblation is typically image-guided and requires careful planning. It is not a 'quick outpatient hack.' It is a serious oncologic procedure\u2014just less invasive in the right scenario."
        },
        {
            "type": "text",
            "title": "When ablation is considered (best-fit scenarios)",
            "content": "Ablation is most often discussed when the tumor is: small and localized, and accessible without excessive risk to the collecting system, ureter, bowel, or major vessels.\n\nCommon situations where ablation may be considered: Small renal tumors in a favourable location. Patients where kidney preservation is particularly important. Patients with higher surgical risk due to comorbidities. Patients where a minimally invasive approach is desirable and oncologically reasonable. Selected cases where biopsy and imaging support an ablation strategy.\n\nAblation is a candidate-specific option. At MyDocsy, our cancer care team regularly rejects patients who are not a fit for the procedure."
        },
        {
            "type": "text",
            "title": "When ablation may not be appropriate",
            "content": "Ablation may be less suitable when: the tumor is large, the lesion is in a location where complete ablation is less reliable, critical structures are too close, imaging suggests more complex disease behaviour, the clinical context suggests a surgery-first approach would provide more definitive control.\n\nThe safest cancer care is not the least invasive care\u2014it is the right care."
        },
        {
            "type": "composite",
            "title": "What evaluation is needed before deciding",
            "items": [
                {
                    "title": "1) Contrast imaging (CT or MRI)",
                    "body": [
                        {
                            "type": "text",
                            "content": "Characterize the lesion (solid vs cystic), determine size and location precisely, assess relation to collecting system and vessels, evaluate whether it appears localized."
                        }
                    ]
                },
                {
                    "title": "2) Kidney function (creatinine/eGFR)",
                    "body": [
                        {
                            "type": "text",
                            "content": "Influences imaging choice, influences how strongly kidney-sparing approaches are prioritized, affects long-term follow-up planning."
                        }
                    ]
                },
                {
                    "title": "3) Biopsy (selected, not done always)",
                    "body": [
                        {
                            "type": "text",
                            "content": "Biopsy may be considered when: pathology would change management, lesion characteristics are indeterminate, ablation is planned and histology confirmation is important."
                        }
                    ]
                },
                {
                    "title": "4) Staging (risk-based)",
                    "body": [
                        {
                            "type": "text",
                            "content": "Staging intensity should match tumor features and risk category."
                        },
                        {
                            "type": "links",
                            "items": [
                                {
                                    "href": "/specialties/urology/conditions/kidney-tumor",
                                    "label": "Related: Kidney Tumor"
                                }
                            ]
                        }
                    ]
                }
            ]
        },
        {
            "type": "text",
            "title": "Cryo vs microwave vs RFA: how the tool is chosen",
            "content": "Patients often ask which energy is 'best.' Usually, the better question is: Which tool is safest and most reliable for my tumor's size and location?\n\nIn general terms: Cryoablation can be attractive for certain lesions because the 'ice ball' can be visualized on imaging, aiding margin control. Microwave and RFA are heating-based approaches; tool choice can depend on tumor size, location, and operator experience.\n\nThe practical truth: outcomes depend heavily on candidacy, planning, and operator expertise, not only the tool name."
        },
        {
            "type": "text",
            "title": "How ablation is performed",
            "content": "Exact protocols vary, but the general flow is: Pre-procedure planning using imaging to determine approach and safety. Procedure performed under appropriate anesthesia/sedation. Image guidance (CT/US guidance) to place probe(s) into tumor. Energy applied to create an ablation zone covering tumor with a safety margin. Post-procedure monitoring for pain, bleeding risk, and kidney function stability. Discharge and follow-up plan provided clearly."
        },
        {
            "type": "composite",
            "title": "Recovery and timelines",
            "items": [
                {
                    "title": "First 24\u201372 hours",
                    "body": [
                        {
                            "type": "text",
                            "content": "Soreness at access site. Mild fatigue. Monitoring for urine changes and discomfort. Instructions on hydration and activity."
                        }
                    ]
                },
                {
                    "title": "First 1\u20132 weeks",
                    "body": [
                        {
                            "type": "text",
                            "content": "Gradual return to routine activity. Avoidance of heavy exertion as advised. Follow-up appointment planning."
                        }
                    ]
                }
            ]
        },
        {
            "type": "text",
            "title": "Risks and side effects",
            "content": "Potential risks include: bleeding (risk varies by tumor location and patient profile), injury to nearby structures (rare, but a known risk), urine leak or collecting system irritation in selected lesion locations, infection (uncommon), incomplete ablation or recurrence requiring repeat treatment or surgery.\n\nUrgent warning signs: fever/chills, severe flank pain, heavy blood in urine, dizziness/fainting, markedly reduced urine output."
        },
        {
            "type": "text",
            "title": "Follow-up after ablation (essential)",
            "content": "Follow-up is not optional in ablation. Why: the tumor is treated in place, so success is assessed via imaging response patterns, recurrence or incomplete response must be detected early.\n\nFollow-up typically includes: scheduled imaging at defined intervals, kidney function monitoring, symptom review, plan for action if imaging is uncertain."
        },
        {
            "type": "composite",
            "title": "Ablation vs partial nephrectomy: how to think",
            "items": [
                {
                    "title": "Partial nephrectomy",
                    "body": [
                        {
                            "type": "text",
                            "content": "Removes tumor as a specimen. Provides pathology and margins. Widely used kidney-sparing surgery in appropriate cases. Involves a more significant surgical recovery."
                        }
                    ]
                },
                {
                    "title": "Ablation",
                    "body": [
                        {
                            "type": "text",
                            "content": "Treats tumor in place. Less invasive recovery in suitable cases. Requires strict follow-up imaging protocol. Candidacy depends strongly on tumor size/location and patient profile.\n\nA good clinician will tell you clearly which option is most reliable for your tumor pattern."
                        }
                    ]
                }
            ]
        },
        {
            "type": "faq",
            "title": "FAQs",
            "items": [
                {
                    "q": "Does ablation work for all kidney cancers?",
                    "a": "No. It is best suited to selected small, localized tumors in favourable locations. Larger or complex tumors often need surgical pathways."
                },
                {
                    "q": "Do I need a biopsy before ablation?",
                    "a": "Sometimes. Biopsy is used when it will change management or when histology confirmation is important."
                },
                {
                    "q": "Is cryo better than microwave or RFA?",
                    "a": "Not universally. Tool choice depends on tumor characteristics and operator experience."
                },
                {
                    "q": "What if ablation doesn't completely treat the tumor?",
                    "a": "Follow-up imaging detects incomplete response early. Some cases can be retreated with ablation; others may require surgery."
                },
                {
                    "q": "Is recovery faster than surgery?",
                    "a": "Often, yes\u2014especially for suitable candidates. But it is still a serious procedure."
                },
                {
                    "q": "Will I lose my kidney?",
                    "a": "Ablation is kidney-sparing by intent. The goal is to treat the tumor while preserving healthy kidney tissue."
                }
            ]
        },
        {
            "type": "text",
            "title": "Talk to a doctor / see if you are a fit",
            "content": "If you are considering kidney tumor ablation, share: CT/MRI report (or images if available), creatinine/eGFR report, any biopsy result, your age and key medical conditions.\n\nWe will guide you on: whether your lesion is a reasonable ablation candidate, what additional imaging or biopsy is worth doing, whether partial nephrectomy is safer/more definitive, what follow-up schedule you should expect."
        },
        {
            "type": "cta",
            "items": [
                {
                    "label": "Upload reports for guidance",
                    "action": "upload"
                },
                {
                    "label": "WhatsApp our medical team",
                    "action": "whatsapp"
                },
                {
                    "label": "Book a renal mass consult",
                    "action": "book"
                }
            ]
        }
    ]
};

export default kidneyTumorAblation;
